Fmoc-L-4-(OtButylcarboxymethyl)phe-OH can be used for peptide synthesis and drug screening.
CAT No: CP27682
CAS No:222842-99-1
Synonyms/Alias:222842-99-1;Fmoc-L-4-(OtButylcarboxymethyl)phe-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-(tert-butoxy)-2-oxoethyl)phenyl)propanoic acid;L-Phenylalanine,4-[2-(1,1-dimethylethoxy)-2-oxoethyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[4-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]phenyl]propanoic acid;MFCD14586316;Fmoc-L-4-(O-tert-butylcarboxymethyl)phe-OH;(2S)-3-{4-[2-(tert-butoxy)-2-oxoethyl]phenyl}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid;AKOS026674178;AS-47826;Fmoc-L-4-(O-t-butylcarboxymethyl)Phe-OH;DS-018197;CS-0199372;Fmoc-L-4-(2-(tert-butoxy)-2-oxoethyl)phe;F16300;(2S)-3-{4-[2-(TERT-BUTOXY)-2-OXOETHYL]PHENYL}-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}PROPANOIC ACID;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(2-(tert-butoxy)-2-oxoethyl)phenyl)propanoicacid;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.